---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-038314"
form_type: "8-K"
ticker: "ICU"
cik: "0001831868"
company_name: "SeaStar Medical Holding Corp"
filed_at: "2025-03-13T23:59:59+00:00"
generated_at: "2026-05-24T21:33:28.666268+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nasdaq panel grants SeaStar Medical continued listing exception until June 22, 2025

## Summary
- Nasdaq Hearings Panel granted continued listing subject to compliance with Nasdaq Listing Rule 5550(b)(2) (MVLS Rule) requiring $35M market value by June 22, 2025.
- Company must file public disclosure describing equity-increasing transactions and provide updated fundraising plans and income projections by June 22, 2025.
- SeaStar is continuing fundraising efforts begun in 2024 and states confidence in meeting all requirements within the specified timeframes.

## SEC filing metadata
- accession: 0000950170-25-038314
- form_type: 8-K
- ticker: ICU
- cik: 0001831868
- company_name: SeaStar Medical Holding Corp
- filed_at: 2025-03-13T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831868/000095017025038314/0000950170-25-038314-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831868/000095017025038314/icu-20250311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-038314
- JSON: https://secwatch.observer/filing/0000950170-25-038314.json
- Plain text: https://secwatch.observer/filing/0000950170-25-038314.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.